<DOC>
	<DOCNO>NCT00447837</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy SPRC-AB01 versus placebo treatment chronic sinusitis subject sinus surgery .</brief_summary>
	<brief_title>Evaluating SPRC-AB01 Post-Surgical Subjects With Chronic Sinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Outpatient subject sign write informed consent . A documented history chronic sinusitis clinical sign symptom suggestive inflammation infection least 90 consecutive day . A documented history sinus surgery &gt; 90 day . Nasal endoscopic exam document purulence ( pu ) open sinus cavity mucosal swelling/edema . Women childbearing potential must negative serum pregnancy test must use adequate birth control throughout study . Pregnant female female unwilling use adequate birth control . Use investigational drug/device within 30 day study screen . The following medication require certain washout period determine protocol : systemic corticosteroid , mast cell and/or leukotriene inhibitor , antiinflammatories , decongestant , antihistamine , nonsteroidal antiinflammatory ( NSAID ) cyclooxygenase ( COX ) 2 inhibitor , antibiotic antifungal . Presence infection may require use systemic antibiotic . Known allergy hypersensitivity aminoglycosides study drug formulation component . Recent hospitalization reason and/or major surgery within 30 day study screen . Major elective and/or nasal and/or sinus surgical procedure ( include sinuplasty ) within 90 day 90 day study screen . Known history neurological muscular disorder . Diagnosis immunodeficiency disease . Previous diagnosis cystic fibrosis , ciliary dyskinesia , Kartagener syndrome , empty nose syndrome , Wegener granulomatosis , ChurgStrauss syndrome , Samter syndrome , sarcoidosis . Current known history tinnitus , vertigo , significant sensorineural hearing loss . Recent history alcohol drug abuse . Inability understand nature , scope , possible consequence study study procedure , unless care legally authorize representative . Inability adhere study requirement . Previous participation Naryx Pharma protocol .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Chronic Sinusitis</keyword>
</DOC>